- Home
- VSTM vs ACTG Comparison
VSTM vs ACTG Comparison
Compare VSTM & ACTG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | VSTM | ACTG |
|---|---|---|
| Founded | 2010 | 1993 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Multi-Sector Companies |
| Sector | Health Care | Miscellaneous |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 470.7M | 384.9M |
| IPO Year | 2011 | 1995 |
Fundamental Metrics
Financial Performance| Metric | VSTM | ACTG |
|---|---|---|
| Price | $3.98 | $4.67 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 7 | 1 |
| Target Price | ★ $16.50 | $6.00 |
| AVG Volume (30 Days) | ★ 2.1M | 199.1K |
| Earning Date | 05-07-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 17.49 | ★ 161.11 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $30,914,000.00 | $12,004,000.00 |
| Revenue This Year | $282.64 | N/A |
| Revenue Next Year | $72.25 | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 209.14 | N/A |
| 52 Week Low | $3.55 | $3.12 |
| 52 Week High | $11.25 | $5.27 |
Technical Indicators
Market Signals| Indicator | VSTM | ACTG |
|---|---|---|
| Relative Strength Index (RSI) | 40.35 | 45.96 |
| Support Level | N/A | $4.51 |
| Resistance Level | $4.53 | $4.78 |
| Average True Range (ATR) | 0.27 | 0.12 |
| MACD | 0.03 | 0.01 |
| Stochastic Oscillator | 40.82 | 31.91 |
Price Performance
Historical ComparisonAbout VSTM Verastem Inc.
Verastem Inc is late-stage development biopharmaceutical company, committed to advancing new medicines for patients battling cancer. Its pipeline is focused on novel anticancer agents that inhibit critical signaling pathways in cancer that promote cancer cell survival and tumor growth, particularly RAF/MEK inhibition and FAK inhibition.
About ACTG Acacia Research Corporation (Acacia Tech)
Acacia Research Corp is focused on acquiring and operating businesses across the industrial, energy, and technology sectors where it believes it can leverage its expertise, capital base, and deep industry relationships to drive value. The company has four reportable business segments: Intellectual Property Operations, Industrial Operations, Energy Operations and Manufacturing Operations. It derives revenue from Intellectual Property Operations segment. Geographically, it operates in Americas, Europe, Middle East and Africa, China, India, and Asia-Pacific, excluding China and India.